Skip to main content

J. Goldman & Co LP

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1412741 NEW YORK, NY

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,046,784
+$3,410,977 QoQ
Shares Held
15,664
+182.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRAX Over Time

Shares Held

Position Value (USD)

Derivatives in PRAX

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$4,381,784
PutShares
13,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $186,588,929 across 52 Biotechnology names. PRAX ranks #8 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 PRAX
Praxis Precision Medicines, Inc.
This page
15,664 $5,046,784

All Filings in PRAX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,046,784 15,664
2026-03-31 $4,381,784 13,600
2025-12-31 $736,850 2,500
2025-12-31 $1,635,807 5,550
2025-12-31 $2,387,394 8,100
2024-12-31 $895,352 11,634
2024-03-31 $752,742 12,336
2023-12-31 $401,040 18,000